Phe-Lys(Trt)-PAB

CAS No. 1116085-99-4

Phe-Lys(Trt)-PAB( —— )

Catalog No. M27000 CAS No. 1116085-99-4

Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 120 Get Quote
10MG 170 Get Quote
25MG 308 Get Quote
50MG 439 Get Quote
100MG 627 Get Quote
200MG 897 Get Quote
500MG 1332 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Phe-Lys(Trt)-PAB
  • Note
    Research use only, not for human use.
  • Brief Description
    Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • Description
    Phe-Lys(Trt)-PAB is a cathepsin cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).(In Vitro):ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1116085-99-4
  • Formula Weight
    640.828
  • Molecular Formula
    C41H44N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N[C@@H](Cc1ccccc1)C(=O)N([C@@H](CCCCNC(c1ccccc1)(c1ccccc1)c1ccccc1)C(N)=O)c1ccc(CO)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.de Veth MJ, et al. Choline absorption and evaluation of bioavailability markers when supplementing choline to lactating dairy cows. J Dairy Sci. 2016 Dec;99(12):9732-9744.
molnova catalog
related products
  • Pinocembrin 7-O-(4,6...

    The herbs of Lindera strychnifolia.

  • Quercetagitrin

    Quercetagitrin isolated from the African Marigold (Tagetes erecta) has anti-inflammatory activity.

  • RUVBL1/2 ATPase-IN-1

    RUVBL1/2 ATPase-IN-1 is an effective RUVBL1/2 ATPase inhibitor with IC50 values of 6.0 and 7.7 μM, respectively. RUVBL1/2 ATPase-IN-1 can be used in cancer disease studies.